Yonsei University College of Medicine, Yonsei Medical Journal, 2(53), p. 439, 2012
DOI: 10.3349/ymj.2012.53.2.439
Full text: Download
We determined the antimicrobial susceptibility of 90 clinical isolates of Stenotrophomonas maltophilia collected in 2009 at a tertiary care hospital in Korea. Trimethoprim-sulfamethoxazole, minocycline, and levofloxacin were active against most of the isolates tested. Moxifloxacin and tigecycline were also active and hold promise as therapeutic options for S. maltophilia infections.